China's Sinopharm mRNA vaccine gets approval for clinical trial

With the increase in corona cases in China, the danger of a new wave is also looming in countries like India, Japan and America. Meanwhile, Chinese drug maker Sinopharm said that its mRNA vaccine has been approved for clinical trials. The company said that it would prove helpful in fighting the Omicron variant. The company has also built a Research and Development Center in Shanghai where 2 billion doses of this vaccine will be made every year.
On Friday (January 20), 145 new cases were reported in India. According to the Health Ministry data, there are currently 1946 active cases in the country. Since the initial phase of Corona, more than 5 lakh people have died in the country.
According to the report of Japan Today, on Saturday (January 20), 82 thousand 614 cases were registered there. The number of corona cases in the capital Tokyo stood at 6,603. The death toll stood at 425. 673 people were admitted to the hospital. After the ban on the citizens of Japan and South Korea, now some people from China have been allowed to enter the country. Visa norms have been relaxed for them.
According to the Corona worldometer, 67 crore 26 lakh 86 thousand 602 cases have been reported so far in the world. On 11 January 2020, a 61-year-old man died in Wuhan, China. This was the first death due to corona in the world. After this the process of death started increasing. So far 67 lakh 40 thousand 520 deaths have taken place.
Sweden, Germany, Malaysia, Qatar, Belgium, Australia, Canada, Morocco, France, UK, Spain, US, Japan, Israel, India, Italy and South Korea have banned travelers coming from China. Here passengers coming from China will have to show negative corona report. Morocco has already banned travelers from China. Taiwan has also made Covid testing compulsory for those coming from China. Pakistan and Philippines are also monitoring. Thailand and New Zealand have declined to impose any restrictions.